Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neuroscience Letters

• Publication date

  1999-10-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0304-3940(99)00712-0PMID 10548412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells.

  1999cited by this paper
• An ethanol‐sensitive variant of the PC12 neuronal cell line: Sensitivity to alcohol is associated with increased cell adhesion and decreased glucose accumulation

  1999cited by this paper
• D2-Like Dopamine Autoreceptor Activation Reduces Quantal Size in PC12 Cells

  1998cited by this paper
• Attachment of PC12 Cells to Adhesion Substratum Induces the Accumulation of Glucose Transporters (GLUTs) and Stimulates Glucose Metabolism

  1998cited by this paper
• Induction of c-fos, jun B and egr-1 expression by haloperidol in PC12 cells: involvement of calcium.

  1995cited by this paper
• Characterization of inhibition by haloperidol and chlorpromazine of a voltage‐activated K+ current in rat phaeochromocytoma cells

  1995cited by this paper
• Dopamine receptor agonists and antagonists enhance ATP-activated currents.

  1992cited by this paper
• Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein.

  1991cited by this paper
• Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.

  1986cited by this paper
• Glucose deprivation and hexose transporter polypeptides of murine fibroblasts.

  1986cited by this paper
• Glucose as a regulator of insulin-sensitive hexose uptake in 3T3 adipocytes.

  1985cited by this paper
• Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.

  1983cited by this paper
• Influence of various substances which induce and inhibit aggregation on the uptake of deoxyglucose by human blood platelets.

  1974cited by this paper
• Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose.

  1972cited by this paper
• Phenothiazines and diabetes in hospitalized women.

  1968cited by this paper
• PHENOTHIAZINE DERIVATIVES AND GLUCOSE METABOLISM.

  1964cited by this paper
• PHENOTHIAZINE DERIVATIVES AND GLUCOSE METABOLISM.

  1964cited by this paper
• HYPERGLYCEMIA AND GLYCOSURIA FOLLOWING CHLORPROMAZINE THERAPY

  1956cited by this paper

• Clinical and molecular implications of antipsychotics in MASLD.

  2025cites this paper
• Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease

  2023cites this paper
• Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke

  2022cites this paper
• An Inhibitory and Beneficial Effect of Chlorpromazine and Promethazine (C+P) on Hyperglycolysis through HIF-1α Regulation in Ischemic Stroke.

  2021cites this paper
• Chlorpromazine Efficiently Treats the Crisis of Pheochromocytoma: Four Case Reports and Literature Review

  2021cites this paper
• DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism

  2021cites this paper
• NDT_A_208061 2087..2099

  2019cites this paper
• Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review

  2019cites this paper
• Reduced Apoptotic Injury by Phenothiazine in Ischemic Stroke through the NOX-Akt/PKC Pathway

  2019cites this paper
• Current Views on Dopaminergic Drugs Affecting Glucose Homeostasis.

  2019cites this paper
• Therapeutic Target and Cell-signal Communication of Chlorpromazine and Promethazine in Attenuating Blood–Brain Barrier Disruption after Ischemic Stroke

  2018cites this paper
• Hibernation-like neuroprotection in stroke by attenuating brain metabolic dysfunction.

  2017cites this paper
• Level of Insulin Resistance in Schizophrenia Patients and Its Association with Treatment with Antipsychotics

  2016cites this paper
• Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke

  2016cites this paper
• Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapy

  2015cites this paper
• Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.

  2015cites this paper
• Atipik Antipsikotiklere Bağli Metabolik Sendrom

  2014cites this paper
• Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.

  2014cites this paper
• Transection method for shortening the rat spine and spinal cord

  2012cites this paper
• Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder.

  2011cites this paper
• Dietary Saturated Fat Intake and Glucose Metabolism Impairments in Nondiabetic, Nonobese Patients with Schizophrenia on Clozapine Or Risperidone

  2010cites this paper
• A double‐blind, placebo‐controlled trial of rosiglitazone for clozapine‐induced glucose metabolism impairment in patients with Schizophrenia

  2009cites this paper
• New Onset Diabetes with Ketoacidosis Attributed to Quetiapine

  2007cites this paper
• At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes.

  2006cites this paper
• Dopamine D2 receptor functional selectivity as a mechanism of atypical antipsychotic drug action

  2006cites this paper
• Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells.

  2006cites this paper
• Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells.

  2006cites this paper
• 403402-Journal vol 5/2 April 04

  2005cites this paper
• Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?

  2005cites this paper
• Schizophrenia and comorbid metabolic disorders.

  2005cites this paper
• Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice

  2005cites this paper
• Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.

  2005cites this paper
• Schizophrenia, Glycemia and Antipsychotic Medications: An Expert Consensus Review

  2005cites this paper
• A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.

  2004cites this paper
• The Role of Atypical Antipsychotics in Glucose/Insulin Dysregulation and the Evolving Role of the Psychiatrist in a New Era of Drug Treatment Options

  2004cites this paper
• Atypical antipsychotics and diabetes mellitus

  2004cites this paper
• Diet and chronic haloperidol effects on rat midbrain dopamine neurons

  2004cites this paper
• Side effects of atypical antipsychotic drugs.

  2004cites this paper
• Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake.

  2003cites this paper
• Low-dose clozapine and diabetic ketoacidosis.

  2003cites this paper
• Risperidone‐Associated Diabetes Mellitus: A Pharmacovigilance Study

  2003cites this paper
• Atypical antipsychotic drugs and diabetes

  2003cites this paper
• Neuronal glucose metabolism and schizophrenia: therapeutic prospects?

  2003cites this paper
• PDNF, a human parasite-derived mimic of neurotrophic factors, prevents caspase activation, free radical formation, and death of dopaminergic cells exposed to the Parkinsonism-inducing neurotoxin MPP+.

  2003cites this paper
• Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism.

  2003cites this paper
• DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor.

  2002cites this paper
• Psychoactive drugs affect glucose transport and the regulation of glucose metabolism.

  2002cites this paper
• Schizophrenia and diabetes.

  2002cites this paper
• Abnormalities in glucose regulation associated with mental illness and treatment.

  2002cites this paper
• Atypical Antipsychotic-Induced Diabetes Mellitus

  2002cites this paper
• Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.

  2002cites this paper
• Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists.

  2002influential citation
• Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine.

  2001cites this paper
• Hyperglycemia and antipsychotic medications.

  2001cites this paper
• Model of the 3‐D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport

  2001cites this paper
• Glucose Metabolism in Relation to Schizophrenia and Antipsychotic Drug Treatment

  2001cites this paper